z` Admission Notice for M.Pharm 2019 at ICT, Mumbai – GPAT DISCUSSION CENTER

  • Admission Notice for M.Pharm 2019 at ICT, Mumbai

    • May 7, 2019
    • Posted By : admin
    • 0 Comment
    •   510 views

    Institute of Chemical Technology (ICT), Mumbai, established in 1933, is one of the world’s most prominent Deemed Universities, funded by the Government of Maharashtra.

    ICT Mumbai offers B.Tech, B.Pharm, Integrated M.Tech, M.Tech, Executive M.Tech, M.Sc. and M.Pharm at UG & PG level. At Research level, the institute also offers Ph.D. in various specializations.

    • For B.Pharm, candidates are selected on the basis of MHT CET score followed by counselling conducted by DTE, Maharashtra.
    • Admission to M.Pharm is done on the basis of GPAT score.

    Course- B.Pharm
    Eligibility- 10+2 examination in Science stream from recognized board
    Selection Process- MHT CET

    Course- M.Pharm
    Specialization-Pharmaceutics, Pharmaceutical Chemistry, Medicinal Natural Products
    Eligibility- B.Pharm with 60% marks
    Selection Process- Valid GPAT score

    Application Process:

    • Visit the official website of the institute and click on the link given for online application.
    • Fill the form carefully by entering the required details and upload the scanned copies of required documents.
    • Pay the application fees via credit/debit card or net banking.

    Documents to be attached with Application Form:

      • SSC and HSC Marksheet
      • Bachelor’s degree Marksheet and Certificate
      • Master’s degree Certificate
      • College Leaving/ Transfer Certificate
      • Caste Certificate
      • Entrance Exam Score Card

    Important Dates-
    Submission of Filled Online Application Form- June 10, 2019
    Display of Eligible Candidates- June 25, 2019
    Online Written Test & Interview- 1st week of June, 2019
    Display of List of Eligible Candidates- 2nd week of June, 2019

    Apply Online:Click Here
    For more detail: Click Here

    0Shares
  510 views

You Might Also Like

No comments found

LEAVE COMMENT

Archive

Offers
error: Content is protected !!